Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim VAN DEN Wyngaert

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
Plos One|April 12, 2019
Second-line erlotinib after failure of pemetrexed-containing chemotherapy in advanced non-small cell lung cancer (NSCLC): Real-world effectiveness, safety and tolerabilityPaul Germonpré, Tim Van den Wyngaert
Seminars in Musculoskeletal Radiology|March 12, 2026
Nuclear Medicine Imaging for Spinal Pain in the Pre- and Postoperative SettingAster Marin, Tim Van den Wyngaert
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 13, 2019
The changing role of radium-223 in metastatic castrate-resistant prostate cancer: has the EMA missed the mark with revising the label?Tim Van den Wyngaert, Bertrand Tombal
World Journal of Nuclear Medicine|February 19, 2019
Ovarian cancer unmasked by technetium-99m bone scintigraphy and single-photon emission computed tomography-computed tomographyJolien Verschueren, Ivan Huyghe, Tim Van den Wyngaert
Frontiers in Oncology|September 14, 2020
Quality Assessment in FDG-PET/CT Imaging of Head-and-Neck Cancer: One Home Run Is Better Than Two DoublesTim Van den Wyngaert, Stijn De Schepper, Laurens Carp
European Journal of Nuclear Medicine and Molecular Imaging|February 26, 2018
FDG-PET/CT for treatment response assessment in head and neck squamous cell carcinoma: a systematic review and meta-analysis of diagnostic performanceNils Helsen, Tim Van den Wyngaert, Laurens Carp, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 10, 2019
Molecular imaging of bone metastases using bone targeted tracersSofia Vaz, Sharjeel Usmani, Gopinath Gnanasegaran, et al.
Biomedicines|May 28, 2022
Radionuclide Imaging of Cytotoxic Immune Cell Responses to Anti-Cancer ImmunotherapyLouis Lauwerys, Evelien Smits, Tim Van den Wyngaert, et al.
Current Opinion in Oncology|June 5, 2007
Osteonecrosis of the jaw related to the use of bisphosphonatesTim Van den Wyngaert, Manon T Huizing, Jan B Vermorken
European Journal of Nuclear Medicine and Molecular Imaging|July 7, 2017
Bone SPECT/CT in the postoperative spine: a focus on spinal fusionKhulood Al-Riyami, Gopinath Gnanasegaran, Tim Van den Wyngaert, et al.
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Plos One|April 12, 2019
Second-line erlotinib after failure of pemetrexed-containing chemotherapy in advanced non-small cell lung cancer (NSCLC): Real-world effectiveness, safety and tolerabilityPaul Germonpré, Tim Van den Wyngaert
Seminars in Musculoskeletal Radiology|March 12, 2026
Nuclear Medicine Imaging for Spinal Pain in the Pre- and Postoperative SettingAster Marin, Tim Van den Wyngaert
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 13, 2019
The changing role of radium-223 in metastatic castrate-resistant prostate cancer: has the EMA missed the mark with revising the label?Tim Van den Wyngaert, Bertrand Tombal
World Journal of Nuclear Medicine|February 19, 2019
Ovarian cancer unmasked by technetium-99m bone scintigraphy and single-photon emission computed tomography-computed tomographyJolien Verschueren, Ivan Huyghe, Tim Van den Wyngaert
Frontiers in Oncology|September 14, 2020
Quality Assessment in FDG-PET/CT Imaging of Head-and-Neck Cancer: One Home Run Is Better Than Two DoublesTim Van den Wyngaert, Stijn De Schepper, Laurens Carp
European Journal of Nuclear Medicine and Molecular Imaging|February 26, 2018
FDG-PET/CT for treatment response assessment in head and neck squamous cell carcinoma: a systematic review and meta-analysis of diagnostic performanceNils Helsen, Tim Van den Wyngaert, Laurens Carp, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 10, 2019
Molecular imaging of bone metastases using bone targeted tracersSofia Vaz, Sharjeel Usmani, Gopinath Gnanasegaran, et al.
Biomedicines|May 28, 2022
Radionuclide Imaging of Cytotoxic Immune Cell Responses to Anti-Cancer ImmunotherapyLouis Lauwerys, Evelien Smits, Tim Van den Wyngaert, et al.
Current Opinion in Oncology|June 5, 2007
Osteonecrosis of the jaw related to the use of bisphosphonatesTim Van den Wyngaert, Manon T Huizing, Jan B Vermorken
European Journal of Nuclear Medicine and Molecular Imaging|July 7, 2017
Bone SPECT/CT in the postoperative spine: a focus on spinal fusionKhulood Al-Riyami, Gopinath Gnanasegaran, Tim Van den Wyngaert, et al.
Pageof 10